Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens AG    SIE   DE0007236101

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2012 | 07:02pm CET

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SIEMENS AG
01/20 Britain seeks bids for 2.75 billion pound high speed train contract
01/19DJU.K.'s May Meets With Wall Street Bank Chiefs--Update
01/19DJU.K.'s May Meets With Wall Street Bank Chiefs
01/19DJMONSANTO : Correction to German Companies on a Tear in U.S. story
01/19DJSIEMENS : German Companies on a Tear in U.S.
01/17 HSBC : China unveils new plan to further open economy to foreign investment
01/13 Centrica completes exit from wind power with Lincs wind farm sale
01/12 SIEMENS : CVC Capital in the lead to acquire MSC Software - sources
01/11 European carmakers hope to catch Tesla with faster e-car chargers
2016 Bankers cautious on outlook for global equity deals after 2016 slide
More news
Sector news : Industrial Conglomerates
12:40a Japan Air Commuter takes first ATR in quest for foreign tourists
01/20 GENERAL ELECTRIC : GE looks for sharp cut in corporate tax rate under Trump
01/20DJGENERAL ELECTRIC : Washington Uncertainty May Give GE an Unhealthy Glow
01/20DJHigher Oil Prices Put Smiles on the Faces of Energy Executives at Davos -- Up..
01/20 CANON CONSIDERING INVESTMENT IN TOSH : Kyodo
More sector news : Industrial Conglomerates
News from SeekingAlpha
01/18 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q4 2016 Update
01/17 Siemens, Biogen to develop new MRI tools
01/12 CLIMATE CHANGE INVESTING : Up In The Air
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016
01/06 IBM WATSON : The Growth Story Finally Unfolding
Advertisement
Financials (€)
Sales 2017 83 870 M
EBIT 2017 8 698 M
Net income 2017 5 827 M
Debt 2017 16 266 M
Yield 2017 3,20%
P/E ratio 2017 16,08
P/E ratio 2018 14,69
EV / Sales 2017 1,38x
EV / Sales 2018 1,31x
Capitalization 99 450 M
More Financials
Chart SIEMENS AG
Duration : Period :
Siemens AG Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Full-screen chart
Technical analysis trends SIEMENS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 118 €
Spread / Average Target 1,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Josef Kaeser President & Chief Executive Officer
Gerhard Cromme Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Helmuth Ludwig Chief Information Officer
Michael Diekmann Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS AG0.17%105 536
GENERAL ELECTRIC COMPA..-3.39%276 096
3M CO-0.04%107 470
HONEYWELL INTERNATIONA..1.70%89 862
E I DU PONT DE NEMOURS..-0.50%63 418
ILLINOIS TOOL WORKS IN..1.05%43 303
More Results